Coherence Breathing Before Cardiopulmonary Exercise Testing

Acute Effects of Coherence Breathing on Cardiopulmonary Exercise Responses in Recreationally Active Adults: A Randomized Crossover Trial

This randomized crossover trial will examine the acute effects of pre-exercise coherence breathing on cardiopulmonary exercise responses in recreationally active adults. Participants will complete two experimental conditions in randomized order: 5 minutes of guided coherence breathing and 5 minutes of quiet seated spontaneous breathing. Following each condition, participants will perform a standardized treadmill warm-up and a maximal cardiopulmonary exercise test. Outcomes will include oxygen consumption, heart rate, heart rate recovery, perceived exertion, time to completion, and heart rate variability. The findings may help determine whether coherence breathing can serve as an effective autonomic priming strategy before a bout of maximal exercise

Study Overview

Detailed Description

Slow-paced breathing performed at approximately six breaths per minute has been shown to influence autonomic nervous system activity and heart rate variability. Coherence breathing may improve physiological regulation by enhancing cardiorespiratory synchronization and vagal modulation. However, little is known about whether a brief bout of coherence breathing performed immediately before exercise can influence cardiopulmonary exercise performance. The purpose of this study is to investigate the acute effects of pre-exercise coherence breathing on cardiopulmonary exercise performance and autonomic responses in recreationally active adults. This study will utilize a randomized, counterbalanced crossover design. Recreationally active adults aged 19 to 45 years will complete two experimental conditions in random order separated by a minimum of 48 hours (maximum of 7 days). In one condition, participants will perform 5 minutes of guided coherence breathing using a visual breathing pacer at approximately 6 breaths per minute while seated. In the comparison condition, participants will sit quietly for 5 minutes with spontaneous breathing. Following each condition, participants will complete a standardized treadmill warm-up and a maximal cardiopulmonary exercise test (CPET). Heart rate variability will be assessed during baseline seated rest and during the breathing intervention. Cardiopulmonary variables collected during CPET will include oxygen consumption, heart rate, respiratory responses, and ratings of perceived exertion. Recovery responses over 5 minutes seated include heart rate and blood pressure will also be assessed following exercise.

Findings from this study may improve our understanding of breathing strategies for athletic performance. Specifically, whether slow paced breathing through coherence breathing can serve as a practical autonomic priming strategy before maximal exercise. Moreover, insights from this study may provide insight into the acute interaction between breathing regulation, autonomic function, and exercise responses.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • New Jersey
      • West Long Branch, New Jersey, United States, 07764
        • Monmouth University Graduate Center, Human Performance Lab, Room 222
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Adults aged 19 to 45 years of any biological sex Recreationally active, defined as accumulating at least 3 hours per week of moderate-to-vigorous physical activity Able to perform maximal cardiopulmonary exercise testing on a treadmill Able to provide informed consent Cleared for moderate-to-vigorous physical activity based on the PAR-Q

Exclusion Criteria:

a) accumulate less than 3 hours per week of moderate or vigorous physical activity; b) have a health condition that is a contraindication for performing maximal exercise test including cardiovascular disease, pulmonary issues, metabolic conditions, neuromuscular disorders, orthopedic limitations, or acute illness that impedes performing the exercise test; d) not completing the study procedures or not providing informed consent and; e) not be able to participate in moderate to vigorous physical activity as determined by the PARQ-2023 questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Coherence Breathing
Participants complete 5 minutes of guided coherence breathing
Participants complete 5 minutes of guided coherence breathing which consists or around 6 breathing cycles (5 seconds inhale and 5 seconds exhale)
Other Names:
  • slow-paced breathing
  • resonance breathing
Active Comparator: Spontaneous Breathing
Participants sit quietly for 5 minutes with spontaneous breathing
Participants sit quietly for 5 minutes with their regular spontaneous breathing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak Oxygen consumption
Time Frame: during each maximal exercise test immediately after the breathing condition
Peak oxygen consumption measured during the maximal cardiopulmonary exercise test (CPET) using a portable metabolic analyzer (Vo2 Master)
during each maximal exercise test immediately after the breathing condition

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
rating of perceived exertion (RPE)
Time Frame: measured at baseline, during the exercise test and after recovery
using the RPE borg scale (from 1-10)
measured at baseline, during the exercise test and after recovery
Heart Rate Recovery
Time Frame: difference between peak HR during CPET and HR at minute 1, minute 2 and minute 5 of recovery.
Heart Rate (bpm) immediately after completing the CPET over a period of 5 minutes
difference between peak HR during CPET and HR at minute 1, minute 2 and minute 5 of recovery.
Time to completion of maximal exercise test
Time Frame: during the exercise test
total duration of the exercise test since test starts to voluntary termination
during the exercise test
Peak Heart Rate
Time Frame: measured during the maximal exercise test
maximal heart rate achieved during the maximal exercise test
measured during the maximal exercise test

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 11, 2026

Primary Completion (Estimated)

September 6, 2026

Study Completion (Estimated)

October 6, 2026

Study Registration Dates

First Submitted

June 10, 2026

First Submitted That Met QC Criteria

June 10, 2026

First Posted (Actual)

June 16, 2026

Study Record Updates

Last Update Posted (Actual)

June 16, 2026

Last Update Submitted That Met QC Criteria

June 10, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Rate Variability (HRV)

Clinical Trials on Coherence Breathing

Subscribe